Baird Medical's presence at the AAES 2025 meeting highlights the growing significance of its MWA technology in the evolving landscape of minimally invasive treatment options for endocrine conditions, particularly thyroid nodules. The participation provides an excellent opportunity for the Company to engage with key opinion leaders in endocrine surgery, share clinical updates on its MWA systems, and contribute to discussions on innovative patient care strategies. The AAES Annual Meeting is widely regarded as ...

Core Insights - Baird Medical is participating in the COSM conference, which is a significant event for the otolaryngology community, aimed at advancing research and clinical education in head and neck surgery [1][2] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatments, focusing on surgical robotic systems and innovative surgical instruments [4] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics in the United States, including Johns Hopkins Hospital and Columbia University Medical Center [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its presence in over 20 countries worldwide [4] Strategic Engagement - The participation in COSM allows Baird Medical to engage with key opinion leaders, clinicians, and researchers, showcasing its portfolio of minimally invasive solutions [2][3] - The company aims to collaborate with healthcare professionals to explore innovative approaches and integrated care strategies to improve patient outcomes in otolaryngology [3]